Anzeige
Mehr »
Montag, 09.03.2026 - Börsentäglich über 12.000 News
Der 9,5 Mio. € Kupferfehler des Marktes - Und solche Fehler korrigieren sich schnell
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SoNVIDIA Corporation (NVDA) Halts China-bound H200 Output, Reuters Reports
SoRBC Capital Cuts PT on Broadcom Inc. (AVGO) to $340 From $370 - Here's Why
SoAdvanced Micro Devices, Inc. (AMD) Expands Its Ryzen AI Portfolio With New Ryzen AI 400 Series and Ryzen AI PRO 400 Series Desktop Processors
SoJim Cramer Talked About 11 Stocks: Uber, Robinhood, and More
SoIUX Officially Launches Global Multi-Asset Trading Platform Amid Shifting Monetary Policies
SoDay One (DAWN) Soars 100% on $2.5-Billion Merger
SoSable Offshore (SOC) Soars 74% on Renewed Optimism for Las Flores Pipeline
SoAmprius (AMPX) Soars 52.2% on Analyst Upgrade, Upbeat Outlook
SoTango Therapeutics (TNGX) Soars 52% on Buy Reco
SoWix.com (WIX) Climbs 33% on Revenue Growth, Aggressive Buyback
SoIovance (IOVA) Soars 33%, Hits All-Time High
SoVenture Global (VG) Climbs 28.8% on Earnings Blowout, Dividend
SoIntapp (INTA) Soars 24% on $1-Billion AI Revenue Target
SoThe Trade Desk (TTD) Soars 22.9% on OpenAI Partnership
SoSamsara (IOT) Climbs 22% as Firm Moves Closer to Profitability
So10 Stocks Investors Are Watching Closely This Week
Sa10 Best Low-Priced AI Stocks to Buy Now
Sa10 Best New Penny Stocks to Buy
Sa10 Best-Performing S&P 500 Stocks in the Last 2 Years
Sa12 Most Promising Stocks Under $20
SaTempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine
SaTeradyne, Inc. (TER) a Moderate Buy, Say Analysts
SaWall Street Bullish on Robinhood Markets, Inc. (HOOD) with Strong Buy
SaHere Is What You Need To Know Before Investing In Advanced Micro Devices, Inc. (AMD)
SaCRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street